Laurus Labs inks JV agreement with KRKA, Slovenia
The registered capital of the newly founded company is € 50 million
The registered capital of the newly founded company is € 50 million
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Subscribe To Our Newsletter & Stay Updated